FI761806A - - Google Patents

Info

Publication number
FI761806A
FI761806A FI761806A FI761806A FI761806A FI 761806 A FI761806 A FI 761806A FI 761806 A FI761806 A FI 761806A FI 761806 A FI761806 A FI 761806A FI 761806 A FI761806 A FI 761806A
Authority
FI
Finland
Application number
FI761806A
Inventor
Hans-Bodo Koenig
Karl Georg Metzger
Michael Preiss
Wilfried Schroeck
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI761806A publication Critical patent/FI761806A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI761806A 1975-06-24 1976-06-22 FI761806A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528077 DE2528077A1 (de) 1975-06-24 1975-06-24 Beta-lactamantibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
FI761806A true FI761806A (fi) 1976-12-25

Family

ID=5949818

Family Applications (1)

Application Number Title Priority Date Filing Date
FI761806A FI761806A (fi) 1975-06-24 1976-06-22

Country Status (17)

Country Link
JP (1) JPS523094A (fi)
AT (1) AT348118B (fi)
AU (1) AU498095B2 (fi)
BE (1) BE843343A (fi)
CH (1) CH628056A5 (fi)
DD (1) DD132344A5 (fi)
DE (1) DE2528077A1 (fi)
DK (1) DK281176A (fi)
ES (1) ES449142A1 (fi)
FI (1) FI761806A (fi)
FR (1) FR2317302A1 (fi)
GB (1) GB1539053A (fi)
GR (1) GR60559B (fi)
IL (1) IL49848A0 (fi)
LU (1) LU75216A1 (fi)
NL (1) NL7606788A (fi)
SE (1) SE7607217L (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
JPS61246187A (ja) * 1985-09-05 1986-11-01 Shionogi & Co Ltd 1―オキサデチアセファム化合物の製造方法
JPH02117677A (ja) * 1989-09-22 1990-05-02 Shionogi & Co Ltd 1―オキサデチアセフアム化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2233067A1 (en) * 1973-06-12 1975-01-10 Beecham Group Ltd N-(thio)acyl carbamoyl-glycylamino-cephalosporin ic acids - as antibiotics esp. active against pseudomonas and gram neg. organisms producing cephalosporinase
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel

Also Published As

Publication number Publication date
CH628056A5 (en) 1982-02-15
LU75216A1 (fi) 1977-03-15
DK281176A (da) 1976-12-25
FR2317302B1 (fi) 1980-07-11
SE7607217L (sv) 1976-12-25
IL49848A0 (en) 1976-08-31
GB1539053A (en) 1979-01-24
NL7606788A (nl) 1976-12-28
AU1522276A (en) 1978-01-05
DE2528077A1 (de) 1977-01-20
GR60559B (en) 1978-06-22
AU498095B2 (en) 1979-02-08
AT348118B (de) 1979-01-25
FR2317302A1 (fr) 1977-02-04
ES449142A1 (es) 1977-07-16
ATA461376A (de) 1978-06-15
DD132344A5 (de) 1978-09-20
JPS523094A (en) 1977-01-11
BE843343A (fr) 1976-12-24

Similar Documents

Publication Publication Date Title
JPS5642196B2 (fi)
FR2317302B1 (fi)
JPS5424472Y2 (fi)
JPS51125492U (fi)
JPS5213381U (fi)
JPS5420511Y2 (fi)
JPS51115633U (fi)
JPS5197583U (fi)
JPS5238429U (fi)
JPS5243123U (fi)
CH582554A5 (fi)
CH599479A5 (fi)
BG22147A1 (fi)
BG22239A1 (fi)
BG22315A1 (fi)
BG22771A1 (fi)
CH1092575A4 (fi)
CH1426175A4 (fi)
CH575785A5 (fi)
CH596120A5 (fi)
CH596351A5 (fi)
CH577663A5 (fi)
CH579998A5 (fi)
CH582390A5 (fi)
BG21347A1 (fi)